financetom
Business
financetom
/
Business
/
Update: AGF Management Down 5.5% as it Posts Lower Q2 Adjusted Earnings
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: AGF Management Down 5.5% as it Posts Lower Q2 Adjusted Earnings
Jun 26, 2024 9:28 AM

12:07 PM EDT, 06/26/2024 (MT Newswires) -- AGF Management (AGF-B.TO) on Wednesday reported lower adjusted earnings for its fiscal second quarter ended May 31.

The company's adjusted profit, excluding most one-time items, totaled $23.6 million, or $0.35 per share, dropping 24% from $31.2 million, or $0.46, in the year-prior period.

Total net revenue inched up to $97 million from $95.8 million. Adjusted EBITDA fell to $37 million from $43.9 million.

The company declared a dividend of $0.115 per share, up from $0.11 per share.

"Our solid results reflect the continued strength of our investment performance driven by our disciplined investment approach and bolstered by stronger than anticipated equity market conditions over the past quarter," said chief executive Kevin McCreadie.

AGF's Class B shares were last seen down $0.48 to $8.23 on the Toronto Stock Exchange.

Price: 8.23, Change: -0.48, Percent Change: -5.51

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Blueprint Medicines Expects Systemic Mastocytosis Franchise to Generate $4 Billion by 2030 -- Shares Up
Blueprint Medicines Expects Systemic Mastocytosis Franchise to Generate $4 Billion by 2030 -- Shares Up
Jan 13, 2025
12:12 PM EST, 01/13/2025 (MT Newswires) -- Blueprint Medicines ( BPMC ) said Monday it now projects the peak revenue opportunity for its systemic mastocytosis franchise at $4 billion, with Ayvakit likely to achieve annual revenue of $2 billion by 2030. The company said its BLU-808 treatment for mast cell disorders was well-tolerated at all doses tested in a phase...
First Atlantic Nickel Acquires RPM South Claims at the Atlantic Nickel Project
First Atlantic Nickel Acquires RPM South Claims at the Atlantic Nickel Project
Jan 13, 2025
12:10 PM EST, 01/13/2025 (MT Newswires) -- First Atlantic Nickel ( FANCF ) Monday said it acquired a 100% interest in mining license 038152M, consisting of 12 mineral claims in central Newfoundland, known as the the RPM South claims. The claims are situated immediately south of the recent discovery at the RPM Zone, which is part of the 30-kilometer nickel...
Constellation Brands Shares Likely to See Limited Downside, RBC Says
Constellation Brands Shares Likely to See Limited Downside, RBC Says
Jan 13, 2025
12:10 PM EST, 01/13/2025 (MT Newswires) -- Constellation Brands ( STZ ) is likely to see limited downside on its share price as the current valuation is implying no long-term growth, RBC Capital Markets said in a note Monday. At its current Street valuation (12.1x FY26E EPS), STZ shares imply 0% topline growth long-term, which places it in line with...
Sysco Workers Prepare to Strike After Negotiations Fail, Labor Union Says
Sysco Workers Prepare to Strike After Negotiations Fail, Labor Union Says
Jan 13, 2025
12:08 PM EST, 01/13/2025 (MT Newswires) -- Sysco ( SYY ) workers are preparing to strike after the company pulled out of negotiations, the Teamsters union said in a statement Monday. According to the union, over 430 Sysco ( SYY ) drivers, warehouse workers, and mechanics represented by the Teamsters are planning to strike after both sides failed to reach...
Copyright 2023-2026 - www.financetom.com All Rights Reserved